CAR T-cell therapy granted orphan designationMay 4, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin Lymphoma
CHMP recommends approving drug to treat FLMay 2, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Costs for orally administered cancer drugs on the riseApril 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
NIH stops production at 2 facilitiesApril 24, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Drug granted breakthrough designation for cHLApril 19, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
PD-1 inhibitor granted priority review for cHLApril 15, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
FDA grants drug accelerated approval for CLLApril 12, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
EMA recommends orphan designation for cancer vaccineApril 6, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA grants product orphan designation for AMLApril 1, 2016Leukemia, Myelodysplasia, TransplantationPharmacyTransplantationAML
